|
by Posted on Thursday, July 03, 2008 7:29:41 AM Sign Up to receive Daily News Alerts in your E-mail Inbox  
PK Accelerator Bundled Solution Accelerates Pharmacokinetic Analysis and Reporting
MOUNTAIN VIEW, Calif., June 24 -- Pharsight Corporation (NASDAQ:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that it will be launching PK Accelerator (PKA(TM)), a system of bundled software coupled with a rapid deployment service provided at a fixed price and fixed scope. Adopting PK Accelerator will allow small to mid-sized organizations to deploy Pharsight''s "best practices" solution for end-to-end pharmacokinetic analysis and validatable CFR 21 part 11 reporting in as little as 90 days.
[Click to continue]  |
|
|
|
|